An overview of drug drug development process
Short Communication
Keywords:
Clinical studies, preclinical studies, target validation, lead optimisation, novel drug discoveryAbstract
Drug design, sometimes referred to as just rational design or rational drug design. It is described as the form of molecules to predict how they will mix with other molecules or bind to cell receptors. Candidate identification, synthesis, characterisation, validation, optimisation, screening, and tests for therapeutic efficacy are all steps in this process. In order to create a medication that satisfies all regulatory standards and is safe and effective, the new medication's creation method must proceed through multiple stages. Prior to conducting clinical trials, the medication development process starts as soon as these investigations show how important the chemical is. To create a medication that satisfies all legal, regulatory, and safety standards, it must pass multiple stages of development. One recurring topic in our writings is that For any new medicine that is eventually approved for clinical usage, a number of biological targets must be taken into consideration due to the lengthy, intricate, and costly procedure. To explore new targets, it can be necessary to examine new research tools. It takes a lot of time and effort to go from a drug's initial discovery to its commercialization. A $1 billion investment is needed throughout the course of twelve to fifteen years, from drug research to approval. Only one of the one million molecules that are screened on average will be studied in advanced clinical trials and eventually given to patients. An overview of the procedures involved in finding and developing novel drugs is given in this article
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Pharma Insights and Research

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.